Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sulfadoxine-pyrimethamine for Malaria Control in Infants
NCT00206739Phase 4Completed
- Sponsor
- Bernhard Nocht Institute for Tropical Medicine
- Start
- Jan 2003
- Primary completion
- Sep 2005
- Modality
- Classical Binding Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of sulfadoxine and pyrimethamine in malaria and anemia (2 arms), sponsored by Bernhard Nocht Institute for Tropical Medicine. Primary endpoints: Proportion and rates of children with one or more episodes of clinical malaria or anemia, Rate of clinical malaria and anemia after suspending treatment and 1 more. Started Jan 2003; status: completed.
02
Drugs
sulfadoxinepyrimethamine
03
Conditions
malariaanemia
Beyond the preview
Go deeper on NCT00206739.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00206739.